Detalles de la búsqueda
1.
Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy.
Breast Cancer Res Treat
; 180(3): 647-655, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32060783
2.
A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial.
Oncologist
; 24(12): e1409-e1416, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31420467
3.
Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II).
J Neurooncol
; 144(2): 303-311, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31392595
4.
Randomized phase 2 trial of pemetrexed, pemetrexed/bevacizumab, and pemetrexed/carboplatin/bevacizumab in patients with stage IIIB/IV non-small cell lung cancer and an Eastern Cooperative Oncology Group performance status of 2.
Cancer
; 124(9): 1982-1991, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29451696
5.
Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non-small cell lung cancer: A randomized, placebo-controlled phase 2 trial with correlated serum proteomic signatures.
Cancer
; 124(11): 2355-2364, 2018 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29645086
6.
A phase 2 study of the sphingosine-1-phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma.
Cancer
; 123(4): 576-582, 2017 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27727447
7.
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.
Breast Cancer Res Treat
; 164(3): 649-658, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28508185
8.
First-Line Carboplatin, Pemetrexed, and Panitumumab in Patients with Advanced Non-Squamous KRAS Wild Type (WT) Non-Small-Cell Lung Cancer (NSCLC).
Cancer Invest
; 35(8): 541-546, 2017 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28762849
9.
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial.
Lancet Oncol
; 17(3): 378-388, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26794930
10.
Use of a multiplexed immunoassay (PRO Onc assay) to detect HER2 abnormalities in circulating tumor cells of women with HER2-negative metastatic breast cancer: lack of response to HER2-targeted therapy.
Breast Cancer Res Treat
; 160(1): 41-49, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27632289
11.
A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma.
J Neurooncol
; 129(2): 281-8, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27311730
12.
Paclitaxel/carboplatin with or without belinostat as empiric first-line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial.
Cancer
; 121(10): 1654-61, 2015 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25611313
13.
Increased survival with enzalutamide in prostate cancer after chemotherapy.
N Engl J Med
; 367(13): 1187-97, 2012 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-22894553
14.
Efficacy and safety of vismodegib in advanced basal-cell carcinoma.
N Engl J Med
; 366(23): 2171-9, 2012 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-22670903
15.
A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score.
Breast Cancer Res Treat
; 154(2): 299-308, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26507191
16.
Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer.
Breast Cancer Res Treat
; 152(3): 557-67, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26155975
17.
Paclitaxel, bevacizumab, and everolimus/placebo as first-line treatment for patients with metastatic HER2-negative breast cancer: a randomized placebo-controlled phase II trial of the Sarah Cannon Research Institute.
Breast Cancer Res Treat
; 154(1): 89-97, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26456573
18.
Pazopanib and liposomal doxorubicin in the treatment of patients with relapsed/refractory epithelial ovarian cancer: a phase Ib study of the Sarah Cannon Research Institute.
Cancer Invest
; 33(3): 47-52, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25615852
19.
Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma.
Haematologica
; 100(5): 670-6, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25710456
20.
Impact of Previous Somatostatin Analogue Use on the Activity of Everolimus in Patients with Advanced Neuroendocrine Tumors: Analysis from the Phase III RADIANT-2 Trial.
Neuroendocrinology
; 102(1-2): 18-25, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25824001